Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Clarification of Optimal Anticoagulation Through Genetics

ClinicalTrials.gov ID: NCT00839657

Public ClinicalTrials.gov record NCT00839657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center, Double-Blind Clinical Trial to Evaluate the Use of Clinical Plus Genetic Information to Guide Warfarin Therapy Initiation and Improve Anticoagulation Control for Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Individuals taking warfarin often need frequent dose changes as the international normalized ratio (INR) gets too high or too low which could result in a higher risk of thromboembolism, bleeding and early discontinuation of a highly useful therapy. This study will compare two approaches to warfarin dosing to examine the utility of using genetic information for warfarin dosing.

Study identification

NCT ID
NCT00839657
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,015 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Apr 2013 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Apr 20, 2016

2009 – 2013

United States locations

U.S. sites
18
U.S. states
16
U.S. cities
18
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35249 —
University of California San Francisco San Francisco California 04143-0131 —
University of Florida Gainesville Florida 32610-0486 —
Georgia Health Sciences University Augusta Georgia 30912 —
Tulane University Health Science Center New Orleans Louisiana 70112 —
University of Maryland School of Medicine Baltimore Maryland 21201 —
Henry Ford Hospital Detroit Michigan 48202 —
Mayo Clinic College of Medicine Rochester Minnesota 55905 —
Washington University School of Medicine St Louis Missouri 63110 —
Mount Sinai School of Medicine New York New York 10029 —
Montefiore Medical Center The Bronx New York 10467 —
Duke University Durham North Carolina 27710 —
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 —
Vanderbilt University Nashville Tennessee 37232 —
University of Texas Medical Branch Galveston Texas 77555 —
Intermountain Medical Center Murray Utah 84157-7000 —
University of Utah Health Care Salt Lake City Utah 84132 —
Marshfield Clinical Research Foundation Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00839657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2016 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00839657 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →